Balaji Agoram
About Balaji Agoram
Balaji Agoram is the Vice President and Head of Clinical Pharmacology at Arcus Biosciences, with extensive experience in clinical pharmacology and development sciences. He previously held leadership roles at MedImmune, Forty Seven, Inc., and Pfizer, and has a strong background in mentoring and team leadership.
Current Role at Arcus Biosciences
Balaji Agoram serves as Vice President and Head of Clinical Pharmacology at Arcus Biosciences. He has held this position since 2021, contributing to the company's focus on innovative cancer therapies. His role involves overseeing clinical pharmacology strategies and ensuring effective collaboration across various departments within the organization. Agoram's leadership is integral to advancing the clinical development of new treatments.
Previous Experience at MedImmune
Agoram worked at MedImmune from 2010 to 2017, where he held the position of Director of Clinical Pharmacology/DMPK for seven years. During his tenure, he contributed to the development of pharmacokinetic strategies and supported various drug development programs. He also served as Clinical Pharmacology Head from 2015 to 2017, further enhancing his expertise in clinical pharmacology.
Experience at Forty Seven, Inc.
From 2017 to 2021, Agoram was the Head of Department at Forty Seven, Inc. He managed clinical pharmacology, DMPK, and bioanalytical functions during his four-year tenure. His leadership in this role focused on integrating pharmacology insights into clinical development processes, supporting the company's mission to develop novel immunotherapies.
Educational Background
Agoram earned a Bachelor of Technology in Chemical Engineering from the Indian Institute of Technology, Madras, where he studied from 1989 to 1993. He later pursued a Doctor of Philosophy at the University of Colorado Boulder, completing his studies from 1994 to 2001. His educational background provides a strong foundation for his extensive work in clinical pharmacology and development sciences.
Professional Affiliations and Expertise
Agoram possesses extensive experience in development sciences, clinical pharmacology, and translational sciences. He has a successful track record in recruiting, mentoring, and leading high-performing scientific teams. Additionally, he served as an Honorary Fellow at the American College of Clinical Pharmacology (ACCP), reflecting his commitment to advancing the field of clinical pharmacology.